Does AD26.COV2.S Cause Off label use? 43 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 43 reports of Off label use have been filed in association with AD26.COV2.S. This represents 9.9% of all adverse event reports for AD26.COV2.S.
43
Reports of Off label use with AD26.COV2.S
9.9%
of all AD26.COV2.S reports
0
Deaths
13
Hospitalizations
How Dangerous Is Off label use From AD26.COV2.S?
Of the 43 reports, 13 (30.2%) required hospitalization, and 2 (4.7%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AD26.COV2.S. However, 43 reports have been filed with the FAERS database.
What Other Side Effects Does AD26.COV2.S Cause?
Covid-19 (58)
Fatigue (47)
Headache (42)
Pain (41)
Pyrexia (40)
Malaise (38)
Arthralgia (32)
Chills (31)
Nausea (25)
Pain in extremity (24)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which AD26.COV2.S Alternatives Have Lower Off label use Risk?
AD26.COV2.S vs ADAGRASIB
AD26.COV2.S vs ADALIMUMAB
AD26.COV2.S vs ADALIMUMAB-AACF
AD26.COV2.S vs ADALIMUMAB-AATY
AD26.COV2.S vs ADALIMUMAB-ADAZ